Načítá se...
Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
SIMPLE SUMMARY: The introduction of immunotherapy modified the cancer treatment landscape, especially for non-small cell lung cancer (NSCLC). Unfortunately, only a subgroup of patients benefits from this therapy. Currently, the only validated companion diagnostic test for first-line immunotherapy in...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036384/ https://ncbi.nlm.nih.gov/pubmed/33918147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071675 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|